Showing titles in Biotechnology

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them.

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

The cells in our bodies consist of molecules, made up of the same carbon, oxygen, and hydrogen atoms found in air and rocks. But molecules, such as water and sugar, are not alive. So how do our cells - assemblies of otherwise "dead" molecules - come to life, and together constitute a living being? In Life’s Ratchet, physicist Peter M. Hoffmann locates the answer to this age-old question at the nanoscale.

Millions of data enthusiasts from around the world compete on Kaggle, the most famous data science competition platform of them all. Participating in Kaggle competitions is a surefire way to improve your data analysis skills, network with an amazing community of data scientists, and gain valuable experience to help grow your career. The first audiobook of its kind, The Kaggle Book assembles in one place the techniques and skills you'll need for success in competitions, data science projects, and beyond.

In 2010, scientists led by J. Craig Venter became the first to successfully create "synthetic life" - putting humankind at the threshold of the most important and exciting phase of biological research, one that will enable us to actually write the genetic code for designing new species to help us adapt and evolve for long-term survival. The science of synthetic genomics will have a profound impact on human existence, including chemical and energy generation, health, clean water and food production, environmental control, and possibly even our evolution.

The first audiobook of its kind, Mind Wars covers the ethical dilemmas and bizarre history of cutting-edge technology and neuroscience developed for military applications. As the author discusses the innovative Defense Advanced Research Projects Agency (DARPA) and the role of the intelligence community and countless university science departments in preparing the military and intelligence services for the 21st century, he also charts the future of national security.

This gripping narrative explores today's scientific pursuit of immortality, with exclusive visits inside Silicon Valley labs and interviews with the visionaries who believe we will soon crack into the aging process and cure death. We live in an age when billionaires are betting their fortunes on laboratory advances to prove aging unnecessary and death a disease that can be cured.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

From the epic of Gilgamesh to the alchemy of the Philosopher’s stone, humanity’s quest for immortality – and its rejuvenation tricks, therapies and tinctures – has always been our most mortal endeavour. But now the giants of invention and investment are building a Fountain of Youth of their own creation. What was once a wild west of experimentation has found its way into Washington’s corridors of power.

A riveting, fast-paced inside look at one of the most incredible private-sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr Albert Bourla, made 'the impossible possible' - creating, testing and manufacturing a safe and effective COIVD-19 vaccine that previously would have taken years to develop.

A shocking expose of the reckless proliferation of bioweapon research and development facilities across the U.S. - and the threat this poses to everyday Americans. Battling a new generation of corporate giants and uncovering threats right in our own backyard, Kenneth King’s Germs Gone Wild reveals the massive expansion of America’s biodefense research labs and the culture of deception surrounding hundreds of facilities that have opened since 9/11.

The Age of Living Machines describes some of the most exciting new developments and the scientists and engineers who helped create them. Virus-built batteries. Protein-based water filters. Cancer-detecting nanoparticles. Mind-reading bionic limbs. Computer-engineered crops. Together they highlight the promise of the technology revolution of the 21st century to overcome some of the greatest humanitarian, medical, and environmental challenges of our time.

The Internet and smartphone are just the latest in a 250-year-long cycle of disruption that has continuously changed the way we live, the way we work, and the way we interact. The coming Augmented Age, however, promises a level of disruption, behavioral shifts, and changes that are unparalleled. While consumers today are camping outside of an Apple store waiting to be one of the first to score a new Apple Watch or iPhone, the next generation of wearables will be able to predict if we're likely to have a heart attack and recommend a course of action.

At a conference in Hong Kong in November 2018, Dr. He Jiankui announced that he had created the first genetically modified babies - twin girls named Lulu and Nana - sending shockwaves around the world. A year later, a Chinese court sentenced Dr. He to three years in prison for "illegal medical practice". As scientists elsewhere start to catch up with China's vast genetic research program, gene editing is fueling an innovation economy that threatens to widen racial and economic inequality. Fundamental questions about science, health, and social justice are at stake.

Ein Blick durch das Schlüsselloch der Forschungslabore und Hightech-Firmen: Woran sie arbeiten, was sie planen, was jetzt schon möglich ist. Spitzenforscher sind sich einig: Auch mit Mitte 90 noch fit zu sein, kann Standard werden. Und 120 Jahre Leben wird für viele Menschen erreichbar – schon für die jetzt geborenen Generationen. Doch was müssen wir tun, um nicht nur länger zu leben, sondern auch länger gesund zu bleiben? Thomas Schulz, langjähriger SPIEGEL-Korrespondent im Silicon Valley, hat mit Konzernchefs und Spitzenforscherinnen, AI-Koryphäen und Medizinerinnen gesprochen.

From the Siberian permafrost to balmy California, scientists across the globe are working to resurrect all kinds of extinct animals, from ones that just left us to those that have been gone for many thousands of years. Their tools in this hunt are both fossils and cutting-edge genetic technologies. Some of these scientists are driven by sheer curiosity; others view the lost species as a powerful weapon in the fight to preserve rapidly changing ecosystems. It seems certain that these animals will walk the earth again, but what world will that give us? And is any of this a good idea?

Supertrends: 50 Things You Need to Know About the Future is about how efficient futurists work and how we can expect the world to evolve in terms of demographics, general economics, technologies, business models, resources, environment, and lifestyles. This audiobook addresses how to predict the future, what we can expect from it, and how companies and government should adapt to the accelerating change.

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health, while contributing trillions of dollars to the global economy. In spite of these past successes - and indeed because of them - our ability to deliver new medicines may be quickly coming to an end. Moving from the 20th century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.

James T. Bradley introduces important biological principles and the basic procedures used in biotechnology. Various ethical issues - personhood, personal identity, privacy, ethnic discrimination, distributive justice, authenticity and human nature, and the significance of mortality in the human life cycle - are presented in a clear and unbiased manner.

Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.